Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Research and Development Expenses 2010-2023 | VRTX

Vertex Pharmaceuticals annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Vertex Pharmaceuticals research and development expenses for the quarter ending December 31, 2023 were $0.825B, a 18.8% increase year-over-year.
  • Vertex Pharmaceuticals research and development expenses for the twelve months ending December 31, 2023 were $3.163B, a 24.51% increase year-over-year.
  • Vertex Pharmaceuticals annual research and development expenses for 2023 were $3.163B, a 24.51% increase from 2022.
  • Vertex Pharmaceuticals annual research and development expenses for 2022 were $2.54B, a 31.09% increase from 2021.
  • Vertex Pharmaceuticals annual research and development expenses for 2021 were $1.938B, a 17.81% increase from 2020.
  
Vertex Pharmaceuticals Annual Research and Development Expenses
(Millions of US $)
2023 $3,163
2022 $2,540
2021 $1,938
2020 $1,645
2019 $1,755
2018 $1,416
2017 $1,325
2016 $1,048
2015 $996
2014 $856
2013 $882
2012 $766
2011 $708
2010 $637
2009 $550
Vertex Pharmaceuticals Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31 $825
2023-09-30 $810
2023-06-30 $786
2023-03-31 $743
2022-12-31 $694
2022-09-30 $645
2022-06-30 $600
2022-03-31 $601
2021-12-31 $566
2021-09-30 $467
2021-06-30 $449
2021-03-31 $456
2020-12-31 $282
2020-09-30 $493
2020-06-30 $421
2020-03-31 $449
2019-12-31 $480
2019-09-30 $556
2019-06-30 $379
2019-03-31 $339
2018-12-31 $438
2018-09-30 $331
2018-06-30 $338
2018-03-31 $311
2017-12-31 $307
2017-09-30 $455
2017-06-30 $289
2017-03-31 $274
2016-12-31 $248
2016-09-30 $272
2016-06-30 $271
2016-03-31 $256
2015-12-31 $310
2015-09-30 $246
2015-06-30 $224
2015-03-31 $216
2014-12-31 $201
2014-09-30 $191
2014-06-30 $224
2014-03-31 $239
2013-12-31 $222
2013-09-30 $219
2013-06-30 $222
2013-03-31 $218
2012-12-31 $173
2012-09-30 $200
2012-06-30 $197
2012-03-31 $196
2011-12-31 $186
2011-09-30 $189
2011-06-30 $174
2011-03-31 $159
2010-12-31 $169
2010-09-30 $170
2010-06-30 $155
2010-03-31 $143
2009-12-31 $135
2009-09-30 $132
2009-06-30 $139
2009-03-31 $144
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $101.905B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.247B 14.42
Bristol Myers Squibb (BMY) United States $99.169B 6.52
Regeneron Pharmaceuticals (REGN) United States $98.437B 23.86
CSL (CSLLY) Australia $83.914B 0.00
Gilead Sciences (GILD) United States $83.121B 9.93
GSK (GSK) United Kingdom $82.379B 10.32
Moderna (MRNA) United States $38.828B 0.00
Biogen (BIIB) United States $28.255B 13.20
Argenex SE (ARGX) Netherlands $21.409B 0.00
BioNTech SE (BNTX) Germany $20.637B 21.07
Genmab (GMAB) Denmark $18.977B 24.32
Illumina (ILMN) United States $18.701B 134.98
Alnylam Pharmaceuticals (ALNY) United States $18.188B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.727B 70.90
BeiGene (BGNE) Cayman Islands $12.387B 0.00
Incyte (INCY) United States $11.754B 19.53
Exact Sciences (EXAS) United States $11.066B 0.00
Sarepta Therapeutics (SRPT) United States $10.857B 0.00
Bio-Techne Corp (TECH) United States $9.765B 36.33
QIAGEN (QGEN) Netherlands $9.128B 18.90
Repligen (RGEN) United States $8.774B 90.83
Roivant Sciences (ROIV) United Kingdom $8.429B 0.00
Legend Biotech (LEGN) United States $8.402B 0.00
Ascendis Pharma (ASND) Denmark $8.161B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Cytokinetics (CYTK) United States $7.064B 0.00
Intra-Cellular Therapies (ITCI) United States $7.006B 0.00
Viking Therapeutics (VKTX) United States $6.990B 0.00
Exelixis (EXEL) United States $6.639B 35.19
Vaxcyte (PCVX) United States $6.616B 0.00
Apellis Pharmaceuticals (APLS) United States $5.731B 0.00
Blueprint Medicines (BPMC) United States $5.315B 0.00
Halozyme Therapeutics (HALO) United States $4.909B 15.15
CRISPR Therapeutics AG (CRSP) Switzerland $4.673B 0.00
Krystal Biotech (KRYS) United States $4.520B 0.00
Zealand Pharma (ZLDPF) Denmark $4.331B 0.00
Immunovant (IMVT) United States $4.100B 0.00
Alkermes (ALKS) Ireland $4.035B 21.30
Nuvalent (NUVL) United States $4.021B 0.00
Insmed (INSM) United States $3.613B 0.00
ImmunityBio (IBRX) United States $3.568B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.487B 0.00
Axsome Therapeutics (AXSM) United States $3.217B 0.00
Biohaven (BHVN) United States $3.190B 0.00
Fortrea Holdings (FTRE) United States $3.173B 0.00
Iovance Biotherapeutics (IOVA) United States $3.159B 0.00
Amicus Therapeutics (FOLD) United States $3.134B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.008B 0.00
SpringWorks Therapeutics (SWTX) United States $2.959B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.875B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.774B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.771B 0.00
IDEAYA Biosciences (IDYA) United States $2.768B 0.00
Arcellx (ACLX) United States $2.752B 0.00
Apogee Therapeutics (APGE) United States $2.742B 0.00
MorphoSys AG (MOR) Germany $2.708B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.695B 0.00
Certara (CERT) United States $2.552B 54.93
Janux Therapeutics (JANX) United States $2.515B 0.00
Arvinas (ARVN) United States $2.372B 0.00
CG Oncology (CGON) United States $2.355B 0.00
Merus (MRUS) Netherlands $2.336B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.286B 0.00
Denali Therapeutics (DNLI) United States $2.281B 0.00
Celldex Therapeutics (CLDX) United States $2.123B 0.00
Vericel (VCEL) United States $2.116B 0.00
Keros Therapeutics (KROS) United States $2.102B 0.00
Intellia Therapeutics (NTLA) United States $2.080B 0.00
Kymera Therapeutics (KYMR) United States $2.076B 0.00
Vera Therapeutics (VERA) United States $2.069B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.064B 0.00
Geron (GERN) United States $2.018B 0.00
Guardant Health (GH) United States $1.956B 0.00
Beam Therapeutics (BEAM) United States $1.952B 0.00
Galapagos (GLPG) Belgium $1.916B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.862B 0.00
Avidity Biosciences (RNA) United States $1.812B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.767B 0.00
NeoGenomics (NEO) United States $1.727B 0.00
Structure Therapeutics (GPCR) United States $1.694B 0.00
Sana Biotechnology (SANA) United States $1.678B 0.00
Myriad Genetics (MYGN) United States $1.674B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.670B 13.87
Bavarian Nordic (BVNRY) Denmark $1.630B 5.35
Inhibrx (INBX) United States $1.627B 0.00
Neumora Therapeutics (NMRA) United States $1.617B 0.00
Twist Bioscience (TWST) United States $1.616B 0.00
Dynavax Technologies (DVAX) United States $1.544B 0.00
Protagonist Therapeutics (PTGX) United States $1.492B 0.00
Akero Therapeutics (AKRO) United States $1.436B 0.00
ADMA Biologics Inc (ADMA) United States $1.431B 0.00
Edgewise Therapeutics (EWTX) United States $1.418B 0.00
Morphic Holding (MORF) United States $1.401B 0.00
Zai Lab (ZLAB) China $1.396B 0.00
ANI Pharmaceuticals (ANIP) United States $1.380B 16.96
Kura Oncology (KURA) United States $1.335B 0.00
Arcus Biosciences (RCUS) United States $1.326B 0.00
Gyre Therapeutics (GYRE) United States $1.325B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.307B 0.00
Ligand Pharmaceuticals (LGND) United States $1.283B 15.89
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.270B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.202B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.194B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.185B 0.00
Spyre Therapeutics (SYRE) United States $1.172B 0.00
Prothena (PRTA) Ireland $1.137B 0.00
AbCellera Biologics (ABCL) Canada $1.133B 0.00
MannKind (MNKD) United States $1.131B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.119B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.110B 0.00
Scholar Rock Holding (SRRK) United States $1.078B 0.00
Vir Biotechnology (VIR) United States $1.069B 0.00
Liquidia Technologies (LQDA) United States $1.010B 0.00
Belite Bio (BLTE) United States $0.974B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.971B 0.00
Abivax SA (ABVX) France $0.963B 0.00
MiMedx (MDXG) United States $0.924B 209.67
Immunome (IMNM) United States $0.924B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.920B 0.00
Viridian Therapeutics (VRDN) United States $0.916B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.881B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.880B 0.00
89BIO (ETNB) United States $0.865B 0.00
Immatics (IMTX) Germany $0.864B 0.00
Tyra Biosciences (TYRA) United States $0.787B 0.00
Kyverna Therapeutics (KYTX) United States $0.785B 0.00
Tango Therapeutics (TNGX) United States $0.780B 0.00
ALX Oncology Holdings (ALXO) United States $0.780B 0.00
Cytek Biosciences (CTKB) United States $0.774B 0.00
REGENXBIO (RGNX) United States $0.769B 0.00
CARGO Therapeutics (CRGX) United States $0.755B 0.00
Pliant Therapeutics (PLRX) United States $0.754B 0.00
PureTech Health (PRTC) United States $0.706B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.705B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.699B 0.00
Disc Medicine (IRON) United States $0.693B 0.00
Dianthus Therapeutics (DNTH) United States $0.682B 0.00
Cullinan Oncology (CGEM) United States $0.674B 0.00
Pharming Group (PHAR) Netherlands $0.671B 0.00
Nurix Therapeutics (NRIX) United States $0.668B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.662B 0.00
EnGene Holdings (ENGN) United States $0.647B 0.00
Cabaletta Bio (CABA) United States $0.644B 0.00
Cogent Biosciences (COGT) United States $0.642B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.628B 0.00
Zymeworks (ZYME) United States $0.625B 0.00
Praxis Precision Medicines (PRAX) United States $0.621B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
Oric Pharmaceuticals (ORIC) United States $0.619B 0.00
Aerovate Therapeutics (AVTE) United States $0.614B 0.00
HilleVax (HLVX) United States $0.612B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.610B 0.00
WAVE Life Sciences (WVE) Singapore $0.596B 0.00
Mesoblast (MESO) Australia $0.594B 0.00
Allogene Therapeutics (ALLO) United States $0.587B 0.00
Northwest Biotherapeutics (NWBO) United States $0.578B 0.00
GH Research (GHRS) Ireland $0.574B 0.00
Nuvation Bio (NUVB) United States $0.567B 0.00
Mineralys Therapeutics (MLYS) United States $0.560B 0.00
Stoke Therapeutics (STOK) United States $0.558B 0.00
Novavax (NVAX) United States $0.556B 0.00
Olema Pharmaceuticals (OLMA) United States $0.555B 0.00
CureVac (CVAC) Germany $0.546B 0.00
Fate Therapeutics (FATE) United States $0.545B 0.00
Prime Medicine (PRME) United States $0.541B 0.00
Absci (ABSI) United States $0.538B 0.00
Astria Therapeutics (ATXS) United States $0.535B 0.00
AnaptysBio (ANAB) United States $0.532B 0.00
Castle Biosciences (CSTL) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Celcuity (CELC) United States $0.525B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.525B 0.00
ArriVent BioPharma (AVBP) United States $0.519B 0.00
ACELYRIN, INC (SLRN) United States $0.493B 0.00
Arbutus Biopharma (ABUS) United States $0.488B 0.00
Alector (ALEC) United States $0.487B 0.00
Oculis Holding AG (OCS) Switzerland $0.477B 0.00
Third Harmonic Bio (THRD) United States $0.476B 0.00
Applied Therapeutics (APLT) United States $0.464B 0.00
C4 Therapeutics (CCCC) United States $0.461B 0.00
Adlai Nortye (ANL) Cayman Islands $0.458B 0.00
Shattuck Labs (STTK) United States $0.455B 0.00
Editas Medicine (EDIT) United States $0.451B 0.00
Humacyte (HUMA) United States $0.441B 0.00
Travere Therapeutics (TVTX) United States $0.435B 0.00
Fulcrum Therapeutics (FULC) United States $0.424B 0.00
IGM Biosciences (IGMS) United States $0.423B 0.00
MaxCyte (MXCT) United States $0.412B 0.00
Annexon (ANNX) United States $0.411B 0.00
Entrada Therapeutics (TRDA) United States $0.408B 0.00
Voyager Therapeutics (VYGR) United States $0.407B 2.43
Lexicon Pharmaceuticals (LXRX) United States $0.406B 0.00
Avid Bioservices (CDMO) United States $0.404B 0.00
Replimune (REPL) United States $0.396B 0.00
Mersana Therapeutics (MRSN) United States $0.394B 0.00
Revance Therapeutics (RVNC) United States $0.394B 0.00
Neurogene (NGNE) United States $0.392B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.391B 0.00
Biomea Fusion (BMEA) United States $0.389B 0.00
Anika Therapeutics (ANIK) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.379B 0.00
Nkarta (NKTX) United States $0.360B 0.00
Aura Biosciences (AURA) United States $0.356B 0.00
Rani Therapeutics Holdings (RANI) United States $0.355B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
Alto Neuroscience (ANRO) United States $0.348B 0.00
Adaptive Biotechnologies (ADPT) United States $0.348B 0.00
Caribou Biosciences (CRBU) United States $0.348B 0.00
PepGen (PEPG) United States $0.341B 0.00
Ocugen (OCGN) United States $0.340B 0.00
Tenaya Therapeutics (TNYA) United States $0.339B 0.00
FibroBiologics (FBLG) United States $0.331B 0.00
Precigen (PGEN) United States $0.331B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.330B 0.00
Solid Biosciences (SLDB) United States $0.329B 0.00
MeiraGTx Holdings (MGTX) United States $0.327B 0.00
TScan Therapeutics (TCRX) United States $0.327B 0.00
Jasper Therapeutics (JSPR) United States $0.325B 0.00
Urogen Pharma (URGN) United States $0.322B 0.00
Ventyx Biosciences (VTYX) United States $0.315B 0.00
Atea Pharmaceuticals (AVIR) United States $0.313B 0.00
Renovaro (RENB) United States $0.312B 0.00
Anavex Life Sciences (AVXL) United States $0.310B 0.00
Nautilus Biotechnology (NAUT) United States $0.308B 0.00
XOMA (XOMA) United States $0.296B 0.00
Terns Pharmaceuticals (TERN) United States $0.295B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.294B 102.20
Monte Rosa Therapeutics (GLUE) United States $0.293B 0.00
Kamada (KMDA) Israel $0.290B 21.96
CorMedix Inc (CRMD) United States $0.289B 0.00
Contineum Therapeutics (CTNM) United States $0.282B 0.00
Inozyme Pharma (INZY) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.278B 0.00
Rapt Therapeutics (RAPT) United States $0.277B 0.00
Invivyd (IVVD) United States $0.274B 0.00
Erasca (ERAS) United States $0.271B 0.00
Werewolf Therapeutics (HOWL) United States $0.256B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
Verastem (VSTM) United States $0.249B 0.00
XBiotech (XBIT) United States $0.245B 0.00
Puma Biotechnology (PBYI) United States $0.242B 10.89
Adverum Biotechnologies (ADVM) United States $0.235B 0.00
Coherus BioSciences (CHRS) United States $0.235B 0.00
AC Immune (ACIU) Switzerland $0.233B 0.00
23andMe Holding (ME) United States $0.233B 0.00
2seventy Bio (TSVT) United States $0.232B 0.00
Ovid Therapeutics (OVID) United States $0.228B 0.00
Sutro Biopharma (STRO) United States $0.227B 0.00
Inovio Pharmaceuticals (INO) United States $0.226B 0.00
UniQure (QURE) Netherlands $0.223B 0.00
G1 Therapeutics (GTHX) United States $0.215B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
X4 Pharmaceuticals (XFOR) United States $0.212B 0.00
Design Therapeutics (DSGN) United States $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
Lifecore Biomedical (LFCR) United States $0.203B 0.00
Compass Therapeutics (CMPX) United States $0.202B 0.00
Skye Bioscience (SKYE) United States $0.199B 0.00
Codexis (CDXS) United States $0.199B 0.00
Prima BioMed (IMMP) Australia $0.198B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
Trevi Therapeutics (TRVI) United States $0.196B 0.00
Poseida Therapeutics (PSTX) United States $0.195B 0.00
Cardiff Oncology (CRDF) United States $0.194B 0.00
Opthea (OPT) Australia $0.193B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.187B 0.00
Elevation Oncology (ELEV) United States $0.185B 0.00
Gossamer Bio (GOSS) United States $0.177B 0.00
Kodiak Sciences (KOD) United States $0.176B 0.00
Alimera Sciences (ALIM) United States $0.175B 0.00
Inventiva S.A (IVA) France $0.175B 0.00
GENFIT S.A (GNFT) France $0.170B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.166B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ScPharmaceuticals (SCPH) United States $0.164B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.162B 0.00
Adicet Bio (ACET) United States $0.160B 0.00
BioStem Technologies (BSEM) $0.157B 0.00
Greenwich LifeSciences (GLSI) United States $0.155B 0.00
INmune Bio (INMB) United States $0.152B 0.00
Candel Therapeutics (CADL) United States $0.152B 0.00
Scilex Holding (SCLX) United States $0.149B 0.00
CervoMed (CRVO) United States $0.148B 0.00
I-Mab (IMAB) China $0.145B 0.00
Zura Bio (ZURA) United States $0.143B 0.00
Cellectis S.A (CLLS) France $0.142B 0.00
Rezolute (RZLT) United States $0.138B 0.00
Omega Therapeutics (OMGA) United States $0.132B 0.00
DBV Technologies S.A (DBVT) France $0.131B 0.00
VistaGen Therapeutics (VTGN) United States $0.129B 0.00
Sagimet Biosciences (SGMT) United States $0.128B 0.00
Syros Pharmaceuticals (SYRS) United States $0.121B 0.00
Nuvectis Pharma (NVCT) United States $0.121B 0.00
Molecular Partners AG (MOLN) Switzerland $0.121B 0.00
TELA Bio (TELA) United States $0.117B 0.00
Coya Therapeutics (COYA) United States $0.117B 0.00
Vor Biopharma (VOR) $0.117B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Adagene (ADAG) China $0.116B 0.00
CytomX Therapeutics (CTMX) United States $0.113B 0.00
Bluebird Bio (BLUE) United States $0.112B 0.00
Agenus (AGEN) United States $0.111B 0.00
Genelux (GNLX) United States $0.111B 0.00
Annovis Bio (ANVS) United States $0.111B 0.00
ATyr Pharma (LIFE) United States $0.109B 0.00
Seer (SEER) United States $0.108B 0.00
Emergent Biosolutions (EBS) United States $0.107B 0.00
Oncobiologics (OTLK) United States $0.106B 0.00
Immunic (IMUX) United States $0.106B 0.00
BioHarvest Sciences (CNVCF) Canada $0.105B 0.00
Vigil Neuroscience (VIGL) United States $0.104B 0.00
BioAtla (BCAB) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.098B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.098B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
PDS Biotechnology (PDSB) United States $0.097B 0.00
Cartesian Therapeutics (RNAC) United States $0.097B 0.00
Allakos (ALLK) United States $0.094B 0.00
Sangamo Therapeutics (SGMO) United States $0.092B 0.00
DiaMedica Therapeutics (DMAC) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.087B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
Elicio Therapeutics (ELTX) United States $0.086B 0.00
Connect Biopharma Holdings (CNTB) United States $0.085B 0.00
Seres Therapeutics (MCRB) United States $0.085B 0.00
Curis (CRIS) United States $0.084B 0.00
BioXcel Therapeutics (BTAI) United States $0.084B 0.00
Eton Pharmaceuticals (ETON) United States $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
Alpha Teknova (TKNO) United States $0.082B 0.00
Athira Pharma (ATHA) United States $0.082B 0.00
Aileron Therapeutics (ALRN) United States $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
InflaRx (IFRX) Germany $0.079B 0.00
Atara Biotherapeutics (ATRA) United States $0.079B 0.00
Affimed (AFMD) Germany $0.078B 0.00
Cue Biopharma (CUE) United States $0.076B 0.00
Spero Therapeutics (SPRO) United States $0.075B 2.80
BeyondSpring (BYSI) United States $0.074B 0.00
AN2 Therapeutics (ANTX) United States $0.074B 0.00
Q32 Bio (QTTB) United States $0.073B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.073B 0.00
HOOKIPA Pharma (HOOK) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Gritstone Bio (GRTS) United States $0.072B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.072B 0.00
Cognition Therapeutics (CGTX) United States $0.072B 0.00
Leap Therapeutics (LPTX) United States $0.072B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.071B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Passage Bio (PASG) United States $0.071B 0.00
Elutia (ELUT) United States $0.071B 0.00
Instil Bio (TIL) United States $0.069B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.069B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Landos Biopharma (LABP) United States $0.068B 0.00
YS Biopharma (YS) China $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Rallybio (RLYB) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Cidara Therapeutics (CDTX) United States $0.062B 0.00
Ocean Biomedical (OCEA) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.061B 0.00
Turnstone Biologics (TSBX) United States $0.061B 0.00
Vaxxinity (VAXX) United States $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
HCW Biologics (HCWB) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
Lantern Pharma (LTRN) United States $0.057B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
Equillium (EQ) United States $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.057B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
AVROBIO (AVRO) United States $0.054B 0.00
Intensity Therapeutics (INTS) United States $0.053B 0.00
Immuneering (IMRX) United States $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.052B 0.00
ARCA Biopharma (ABIO) United States $0.049B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.046B 0.00
Dyadic (DYAI) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Aadi Bioscience (AADI) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
NextCure (NXTC) United States $0.045B 0.00
Beyond Air (XAIR) United States $0.044B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
Apollomics (APLM) United States $0.042B 0.00
Ocuphire Pharma (OCUP) United States $0.041B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.040B 0.00
SAB Biotherapeutics (SABS) United States $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Carmell (CTCX) United States $0.038B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Cara Therapeutics (CARA) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
IN8bio (INAB) United States $0.033B 0.00
Theratechnologies (THTX) Canada $0.033B 0.00
BRIACELL THERAP (BCTX) Canada $0.032B 0.00
BioAffinity Technologies (BIAF) United States $0.032B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Semper Paratus Acquisition (TVGN) United States $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
Eyenovia (EYEN) United States $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Prenetics Global (PRE) Cayman Islands $0.027B 0.00
Evogene (EVGN) Israel $0.025B 0.00
NKGen Biotech (NKGN) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
AEterna Zentaris (AEZS) Canada $0.009B 0.00
Telesis Bio (TBIO) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Trevena (TRVN) United States $0.006B 0.00
Cadrenal Therapeutics (CVKD) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.33
Longeveron (LGVN) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Sunshine Biopharma (SBFM) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00